BillionToOne Strengthens Evidence for Prenatal cfDNA Screening
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
BOSTON, August 18, 2026 Curavit Clinical Research, a next-generation clinical research organization (CRO) and Remote Clinical Site, announced the...
CARY, N.C., June 30, 2026 Allucent, a global specialty Contract Research Organization (CRO) serving small and mid-sized biopharmaceutical companies,...
CONCORD, Calif., USA — April 2, 2026 Panoramic Health, through its clinical research division Panoramic Science, in collaboration with...
DUBLIN, IRELAND | January 27, 2026 — ICON plc, a global clinical research organization, announced a significant expansion of...
